Skip to main content

Table 1 NK ligand primers used for RT-PCR

From: Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand

NK receptor

Ligands

Forward primer

Reverse primer

Amplicon size (bp)

NKG2D

MICA

TCTACTACGATGGGGAGCTCTT

ACTGGGGCATTGTCCATTC

66

 

MICB

CTGAGAAGGTGGCGACGTA

CGAAGACTGTGGGGCTCA

111

 

ULBP-1

TGGGGGATTGTAAGATGTGG

GGCCAGAGAGGGTGGTTT

83

 

ULBP-2

CCGCTACCAAGATCCTTCTG

TGACGGTGATGTCATAGCAAA

105

 

ULBP-3

AGGAAGAAGAGGCTGGAACC

CTATGGCTTTGGGTTGAGCTA

70

 

ULBP-4

GGGAGAATTGACCCAAACG

CTTGCAGAGTGGAAGGATCAC

104

NKG2A/C/E/H

HLA-E

GGAGTGGCTCCACAAATACC

GTCAGAGATGGGGTGGTGAG

94

2DL4

HLA-G

CTGGAGAACGGGAAGGAGAT

GGGTGGCCTCATAGTCAAAG

88

2B4

CD48

CCTACATCATGAGGGTGTTGAA

ATGACAGGCTTGGGTACAGG

91

NTBA

NTBA

CCACAATTAATCATTCCAAAGAGA

TGTCATTCCCGAATTCCTCT

107

LIR2

HLA-F

ATCACCCAGCGCTTCTATGA

CTGGGGAGACTGCTCTGC

138

NKR-P1A

LLT-1

GTTCAGGGCCAGTGCATATT

GACTCTGCACCTTCCTTCACA

61

DNAM-1

PVR-1

CAACGTCACCAATGCCCTA

CTGAGTGCTCACTGGGAGGT

80

 

PVR-2

GATATCTGGCTCCGAGTGCT

TCCAGTGAGCTGGACCTTCT

69

 

Nectin2-1

GGCAGAGGAGGACGAAGAC

GAGCTGGGAGGGCATCTC

94

 

Nectin2-2

GAGGACGAGGGCAACTACAC

GGCCTCAGCTTGGTTCTTG

108

CD100

CD72

TTCTTCACATGCGGCTCA

AGCAGCTTTTCTGATGCATTATC

67

CD28

CD80

TCCTGGGCCATTACCTTAATC

CATCTTGGGGCAAAGCAG

77

LFA-1

ICAM-1

CCTTCCTCACCGTGTACTGG

AGCGTAGGGTAAGGTTCTTGC

90

LFA-2

LFA-3

CATGTATTGTGCTGTATATGAATGGT

TCTGGCTTCCCAAGTAATGG

141

CRACC

CRACC

TCTACTATGTGGGGATATACAGCTCA

TTTAGGCTTTGACAGGTGCTC

92

FasL

Fas

GTGGACCCGCTCAGTACG

TCTAGCAACAGACGTAAGAACGA

112

TRAIL

DR4

GGGTCCACAAGACCTTCAAGT

GGGTCCACAAGACCTTCAAGT

68

 

DR5-1

GTGTGTCAGTGCGAAGAAGG

GACCATCCCTCTGGGACA

90

 

DR5-2

GCACCAGGTGTGATTCAGG

CCCTCTGGGACACCCTGT

143

TNF

TNFR1

CTCTCCACCGTGCCTGAC

CCAGTCCAATAACCCCTGAG

85

  1. CRACC CD2-like receptor activating cytotoxic cell, DNAM-1 DNAX accessory molecule-1, ICAM-1 intercellular adhesion molecule 1, LFA lymphocyte function-associated antigen, MIC MHC I-related chain, NK natural killer, NKG2D NK receptor group 2; membrane D, PVR-1 poliovirus receptor-1, RT-PCR real-time quantitative polymerase chain reaction, TNF tumor necrosis factor, TRAIL tumor necrosis factor-related apoptosis-inducing ligand, ULBP UL16 binding protein